Enochian Biosciences, Inc.

Historical 13F Holders

Symbol
RENB
CUSIP
29350E104
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 29350E104 since 12/18/2024, newest first.

Filer % of Class Filed
William Anderson Wittekind 13D/A Amendment 21 8.0% 7/10/2025
Event 7/9/2025
William Anderson Wittekind 13D/A Amendment 20 10.4% 4/14/2025
Event 4/10/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q1 1 632 $258
2025 Q4 1 473 $417
2025 Q3 1 5.00 $7
2025 Q2 47 14.4 M $4.17M
2025 Q1 64 22.0 M $12.0M
2024 Q4 60 22.1 M $18.5M
2024 Q3 52 14.9 M $7.17M
2024 Q2 41 14.6 M $25.6M
2024 Q1 42 8.12 M $21.5M
2023 Q4 37 2.98 M $9.44M
2023 Q3 22 1.49 M $6.65M
2023 Q2 34 1.85 M $1.13M
2023 Q1 41 3.31 M $3.03M
2022 Q4 40 3.94 M $4.06M
2022 Q3 45 3.79 M $6.87M
2022 Q2 53 3.96 M $7.64M
2022 Q1 44 2.60 M $21.5M
2021 Q4 46 2.47 M $18.0M
2021 Q3 36 1.52 M $10.2M
2021 Q2 38 2.67 M $13.3M
2021 Q1 42 2.71 M $9.60M
2020 Q4 41 2.51 M $7.41M
2020 Q3 40 2.38 M $8.54M
2020 Q2 35 2.47 M $10.4M
2020 Q1 33 2.29 M $6.86M
2019 Q4 34 2.37 M $11.9M
2019 Q3 30 1.17 M $6.43M
2019 Q2 30 1.24 M $5.52M
2019 Q1 20 906 k $6.67M
2018 Q4 4 2.96 k $21.0k